Based on the LEPU MED.T.B. SP.GDR O.N. stock forecast from 0 analysts, the average analyst target price for LEPU MED.T.B. SP.GDR O.N. is not available over the next 12 months. LEPU MED.T.B. SP.GDR O.N.’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of LEPU MED.T.B. SP.GDR O.N. is Slightly Bullish , which is based on 5 positive signals and 3 negative signals. At the last closing, LEPU MED.T.B. SP.GDR O.N.’s stock price was EUR 14.10. LEPU MED.T.B. SP.GDR O.N.’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +2.17% over the last year.
No recent analyst target price found for LEPU MED.T.B. SP.GDR O.N.
No recent average analyst rating found for LEPU MED.T.B. SP.GDR O.N.
Company Overview LEPU MED.T.B. SP.GDR O.N.
Lepu Medical Technology (Beijing) Co., Ltd. engages in the development, manufacture, and distribution of medical devices and equipment in China, India, the Netherlands, and the United States. The company offers peripheral interventional products, including Supercross PTA balloon dilatation catheters and Angiocide peripheral cutting balloon; cardiovascular products, such as coronary stents and balloons, catheter, guide wires, introducer sheaths, fractional flow reserve, and accessories; and neurointerventional products. It also provides digital subtraction angiography system; congenital heart disease products; cardiac rhythm management products that comprise electrophysiology, pacemaker and lead, and equipment; ECG, patient monitor, and oximeter; home medical equipment; critical care products; dialyzer, hemoperfutor, and hemodialysis accessories; in vitro diagnostics comprising hematology, point of care testing, immunoassay, molecular diagnostic, and biochemistry; surgical products, which include ultrasonic surgical system, surgical stapler, endoscopic ultrasound system; portable, trolley, and veterinary ultrasound products; oncology diagnostics; and orthopedic products. In addition, the company offers APIs and FDFs for cardiovascular, anti-infectives, oncology, central nervous system, and other diseases; and offers skin care products under the LEPU LAB brand name; and polymerase chain reaction solutions, SARS-CoV-2 test kits, infrared forehead thermometers, patient monitors, pulse oximeters, sterile syringes, and neutralization antibody test kits. Lepu Medical Technology (Beijing) Co., Ltd. was founded in 1999 and is headquartered in Beijing, China. Address: 37 Chaoqian Road, Beijing, China, 102200 Read Less
Lepu Medical Technology (Beijing) Co., Ltd. engages in the development, manufacture, and distribution of medical devices and equipment in China, India, the Netherlands, and the United States. The company offers peripheral interventional products, including Supercross PTA balloon ...Read More
N/A
N/A
10,652
December
EUR
Germany
Adjusted Closing Price for LEPU MED.T.B. SP.GDR O.N. (07Z0:F)
Loading...
Unadjusted Closing Price for LEPU MED.T.B. SP.GDR O.N. (07Z0:F)
Loading...
Share Trading Volume for LEPU MED.T.B. SP.GDR O.N. Shares
Loading...
Compare Performance of LEPU MED.T.B. SP.GDR O.N. Shares
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Loading...
Technical Indicators for 07Z0:F
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Stocks Similar To LEPU MED.T.B. SP.GDR O.N. (Sector: Medical Devices )
Frequently Asked Questions About LEPU MED.T.B. SP.GDR O.N. (07Z0:F) Stock
Stock Target Advisor's fundamental analysis for LEPU MED.T.B. SP.GDR O.N.'s stock is Slightly Bullish .
07Z0:F stock's dividend yield is 1.55%.
Our analysis grades 07Z0:F stock's dividend yield at F. This means that 07Z0:F stock's dividend yield is above 47% of the stocks in the Medical Devices sector in the F exchange.
Based on this 07Z0:F may be a average dividend stock for its sector.
Unfortunately we do not have enough data on 07Z0:F's stock to indicate what its average analyst target is.
07Z0:F stock's Price/Earning ratio is 117.50.
Our analysis grades 07Z0:F stock's Price / Earning ratio at F. This means that 07Z0:F stock's Price/Earning ratio is above 88% of the stocks in the Medical Devices sector in the F exchange.
Based on this 07Z0:F may be a overvalued for its sector.
The last closing price of 07Z0:F's stock was EUR 14.10.
The most recent market capitalization for 07Z0:F is EUR 4.11B.
Unfortunately we do not have enough analyst data on 07Z0:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains LEPU MED.T.B. SP.GDR O.N.'s stock.
As per our most recent records LEPU MED.T.B. SP.GDR O.N. has 10,652 Employees.
Sorry we do not have any infomation available on LEPU MED.T.B. SP.GDR O.N.'s address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 07Z0:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
